Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

HIV TREATMENT AND PREVENTION: NEW OPPORTUNITIES TO OPTIMIZE DRUG DOSING, ADHERENCE, AND ANTIRETROVIRAL THERAPY

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 13 of 13
INTRODUCTION OF SPEAKERS (PART I)
Angela Kashuba
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
from CROI 2021 on March 8, 2021 11:15 AM-1:15 PM
ISLATRAVIR PK THRESHOLD & DOSE SELECTION FOR MONTHLY ORAL HIV-1 PREP   (ABSTRACT 87)
Munjal Patel
Merck & Co, Inc, Kenilworth, USA
from CROI 2021 on March 8, 2021 11:15 AM-1:15 PM
NEXT-GENERATION ISLATRAVIR IMPLANTS PROJECTED TO PROVIDE YEARLY HIV PROPHYLAXIS   (ABSTRACT 88)
Randolph P Matthews
Merck & Co, Inc, Kenilworth, NJ, USA
from CROI 2021 on March 8, 2021 11:15 AM-1:15 PM
CLINICAL EVALUATION OF DRUG INTERACTIONS WITH ORAL LENACAPAVIR AND PROBE DRUGS   (ABSTRACT 89)
Justin Lutz
Gilead Sciences, Inc, Foster City, CA, USA
from CROI 2021 on March 8, 2021 11:15 AM-1:15 PM
PK AND SAFETY OF HIGH-DOSE RIFAMPICIN IN TB/HIV COINFECTED PATIENTS ON EFV OR DTG   (ABSTRACT 90)
Christine Sekaggya-Wiltshire
Infectious Diseases Institute Makerere University, Kampala, Uganda
from CROI 2021 on March 8, 2021 11:15 AM-1:15 PM
LIVE QUESTIONS AND ANSWERS (PART I) WITH PRESENTERS AND ATTENDEES
Munjal Patel
Merck & Co, Inc, Kenilworth, USA
Angela Kashuba
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Randolph P Matthews
Merck & Co, Inc, Kenilworth, NJ, USA
Justin Lutz
Gilead Sciences, Inc, Foster City, CA, USA
Christine Sekaggya-Wiltshire
Infectious Diseases Institute Makerere University, Kampala, Uganda
from CROI 2021 on March 8, 2021 11:15 AM-1:15 PM
INTRODUCTION OF SPEAKERS (PART II)
Courtney V Fletcher
University of Nebraska Medical Center, Omaha, NE, USA
from CROI 2021 on March 8, 2021 11:15 AM-1:15 PM
PK OF DOSE-ADJUSTED EMERGENCY CONTRACEPTION WITH EFV-BASED ART IN ACTG 5375   (ABSTRACT 91)
Kimberly K Scarsi
University Of Nebraska Medical Center, Omaha, NE, USA
from CROI 2021 on March 8, 2021 11:15 AM-1:15 PM
EMTRICITABINE TRIPHOSPHATE IN DRIED BLOOD SPOTS PREDICTS FUTURE VIREMIA IN PWH   (ABSTRACT 92)
Jose R Castillo-Mancilla
University of Colorado-AMC, Aurora, CO, USA
from CROI 2021 on March 8, 2021 11:15 AM-1:15 PM
TENOFOVIR DIPHOSPHATE TO PREDICT FUTURE VIRAEMIA IN POSTPARTUM WOMEN LIVING WITH HIV   (ABSTRACT 93)
Jasantha Odayar
University of Cape Town, Cape Town, Western Cape, South Africa
from CROI 2021 on March 8, 2021 11:15 AM-1:15 PM
NUCLEOSIDES AND DARUNAVIR/DOLUTEGRAVIR IN AFRICA (NADIA) TRIAL: 48WKS PRIMARY OUTCOME   (ABSTRACT 94)
Nicholas Paton
National University of Singapore, Singapore, Singapore
from CROI 2021 on March 8, 2021 11:15 AM-1:15 PM
RANDOMIZED TRIAL OF RESISTANCE TESTING FOR VIROLOGIC FAILURE IN SUB-SAHARAN AFRICA   (ABSTRACT 95)
Mark Siedner
Harvard Medical School, Boston, MA, USA
from CROI 2021 on March 8, 2021 11:15 AM-1:15 PM
LIVE QUESTIONS AND ANSWERS (PART II) WITH PRESENTERS AND ATTENDEES
Courtney V Fletcher
University of Nebraska Medical Center, Omaha, NE, USA
Kimberly K Scarsi
University Of Nebraska Medical Center, Omaha, NE, USA
Jose R Castillo-Mancilla
University of Colorado-AMC, Aurora, CO, USA
Jasantha Odayar
University of Cape Town, Cape Town, Western Cape, South Africa
Nicholas Paton
National University of Singapore, Singapore, Singapore
Mark Siedner
Harvard Medical School, Boston, MA, USA
from CROI 2021 on March 8, 2021 11:15 AM-1:15 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 13 of 13